Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001731831-18-000001
Filing Date
2018-04-12
Accepted
2018-04-11 20:12:41
Documents
1
Effectiveness Date
2018-04-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9460
  Complete submission text file 0001731831-18-000001.txt   10586
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

EIN.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-309956 | Film No.: 18751015
SIC: 2834 Pharmaceutical Preparations